The Lancet Diabetes & Endocrinology
Explore original research, reviews, and topical comments about diabetes, endocrinology, and metabolism from The Lancet Diabetes & Endocrinology
Related Articles
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterised by the presence of autoantibodies towards nuclear antigens, immune complex deposition, and chronic inflammation at…
Racial and ethnic inequities in the quality of paediatric care in the USA: a review of quantitative evidence
Racial and ethnic inequities in paediatric care have received increased research attention over the past two decades, particularly in the past 5 years, alongside an…
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history
The life history theory assumes that all organisms are under selective pressure to harvest external resources and allocate them to maximise fitness: only organisms making…
CAR T-cell therapy for SLE in children
On March 11, 2024, Seattle Children’s Hospital (Seattle, WA, USA) announced that it had received approval from the US Food and Drug Administration for a…
Evidence with 95-95-95 that ambitious is feasible
When proposed a decade ago, the UNAIDS 90-90-90 targets were described as aggressive, ambitious, and daunting.1 Nevertheless, these milestones have had a profound effect on…
Progress towards the UNAIDS 95-95-95 targets in the Fifth Botswana AIDS Impact Survey (BAIS V 2021): a nationally representative survey
BAIS V is the first population-based survey worldwide to report the achievement of the UNAIDS 95-95-95 goals, both overall and among women. Strategies to reach…
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA1c as the measure of average…
Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study
Our findings support calls to lower or remove the lower limit of current IOM recommendations for pregnant women with obesity, and suggest that separate guidelines…
Pathophysiology and therapeutic options for cirrhotic portal hypertension
Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension…
eClinicalMedicine, April 2024, Volume 70
New general medicine open access journal, published by The Lancet, influencing clinical practice and health policy.
